Polygenic Risk Score and Rare Variant Burden Identified by Targeted Sequencing in a Group of Patients with Pigment Epithelial Detachment in Age-Related Macular Degeneration

Genes (Basel). 2023 Aug 27;14(9):1707. doi: 10.3390/genes14091707.

Abstract

A subset of ophthalmic imaging examination results from 334 patients were subjected to reanalysis to identify a specific group of patients with pigment epithelial detachment (PED) in at least one eye. Overall, we found a subgroup of 47 patients manifesting PED and studied their genotypes in comparison to those of patients with age-related macular degeneration without PED and healthy controls. We established a polygenic risk score that allowed the explanation of 16.3% of the variation within the disease. The highest predictive value was achieved for a model consisting of six non-coding variants: rs760306 (BEST1), rs148662546 (BEST1), rs11569560 (C3), rs74600252 (GUCA1B), rs2240688 (PROM1), and rs185507582 (TCF4). The risk of PED occurrence was found to be the highest in the first tercile, showing a 7.89-fold higher risk compared to the third tercile for AMD without PED (95% CI: 2.87; 21.71, p < 0.001) and a 7.22-fold higher risk compared to the healthy controls (95% CI: 2.60; 20.06, p < 0.001). In addition, we focused on rare variants in targeted genes. The rare variants' burden was compared among the groups, but no statistical significance was observed in the number of rare variants, predicted functional effects, or pathogenicity classification.

Keywords: AMD genetics; PED susceptibility; age-related macular degeneration; pigment epithelial detachment; polygenic model; polygenic risk score.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bestrophins
  • Humans
  • Macular Degeneration* / genetics
  • Retinal Detachment* / genetics
  • Retinal Pigment Epithelium
  • Risk Factors

Substances

  • BEST1 protein, human
  • Bestrophins

Grants and funding

This work was supported by the National Centre for Research and Development grant STRATEGMED1/234261/2/NCBR/2014 and the ministerial program entitled “Doktorat Wdrożeniowy” (III edition).